BYSUMLOG
LIVE

Serial Number

79301288

Owner

NOVARTIS AG

Filing Date

Nov 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BYSUMLOG Trademark

Serial Number: 79301288 • Registration: 6413818

BYSUMLOG is a trademark filed by NOVARTIS AG on November 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

SANDOZ AG (203 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

November 10, 2020

Registration Date

July 13, 2021

Published for Opposition

April 27, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 28, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 16, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 16, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 13, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 25, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
REFUSAL PROCESSED BY IB
Mar 22, 2021 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 19, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 19, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 19, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 19, 2021 CNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 4, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 4, 2021 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 1, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR